SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 1,058-1.6%Dec 1 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lazarre who wrote (117)4/6/1998 4:53:00 PM
From: Anthony Wong  Read Replies (1) of 642
 
Lazarre,

I noticed that LLY started to recover at 11 plus AM (which was before the upgrade, issued at 1:46 PM, and the Evista scripts, newswire out at 12:09 PM). Last time I looked, ZEN was up more than $10 on the news, and nobody knows how far this new indication of tamoxifer is going to translate into scripts. Now, all we need is some news to push LLY back up to a reasonable valuation (compared to the rest of the drug group). If you look at I.Q. chart on LLY (look at the stochastics), there was a buy signal on Friday:
207.95.154.130

Today's reversal, IMHO, is due to
1) stock being very oversold
2) shorts covering because of the news (tamoxifer/Evista and upgrade)
3) some value investors buying?

<Do you have any idea how long it will take for this indication to translate into scripts?>

The scripts news release mentioned "later this year". Perhaps we'll have more information later on.

Regards.

Anthony
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext